If Your Dog’s Gums Are Pale — IMHA Symptoms and Emergency Signs

ImmunityQ&AMeongsiljang Veterinary Advisory Board

Immune-mediated hemolytic anemia (IMHA) is an autoimmune disease in which the immune system mistakenly attacks and destroys the body’s own red blood cells. Because this condition often presents as a medical emergency, early detection and immediate treatment are critical to improving survival rates.

What Is Immune-Mediated Hemolytic Anemia (IMHA)?

A veterinarian checking a puppy's pale gums

Immune-mediated hemolytic anemia (IMHA) is an autoimmune blood disorder in which the immune system mistakenly attacks and destroys the body’s own red blood cells. The most critical aspect is early recognition and prompt hospitalization for treatment. If your pet’s gums appear pale or yellow, or if they are breathing rapidly or showing sudden weakness, seek veterinary care within 24 hours. Delaying treatment can lead to life-threatening complications such as thromboembolism or multiple organ failure, which is why IMHA is classified as an emergency condition.

Causes and Types

IMHA is broadly categorized into two types based on its underlying cause. Primary (idiopathic) IMHA occurs when the immune system malfunctions and attacks red blood cells without any identifiable trigger. In practice, the idiopathic form is common, and cases with no clear precipitating factor are presumed to be autoimmune. Secondary IMHA is triggered by external factors such as infections, medications, tumors, systemic lupus erythematosus (SLE), vaccinations, or tick-borne diseases. There is also a distinct variant called precursor-targeted immune-mediated anemia (PIMA), in which the immune system targets red blood cell precursors during their production in the bone marrow. Differentiating the specific type is crucial, as it directly influences the diagnostic and treatment approach.

Regenerative vs. Non-Regenerative IMHA

Item	Regenerative IMHA	Non-regenerative IMHA (including PIMA)
Target of attack	Mature red blood cells in peripheral blood	Erythroid precursor cells in bone marrow
Reticulocyte count	Increased (regenerative response present)	Normal or decreased (non-regenerative)
Diagnostic difficulty	Relatively easy to confirm with blood tests	Bone marrow examination may be needed
Treatment response	Recovery expected due to regenerative response	Recovery may take longer
Relative frequency	Accounts for the majority of IMHA	Appears less commonly than the regenerative form

Refer to veterinary internal medicine·veterinary clinical pathology textbooks. PIMA targets erythroid precursor cells in the bone marrow and often requires bone marrow evaluation.

Signs That Suggest IMHA

IMHA’s early symptoms can mimic those of other conditions, making it easy to miss. If you notice even one of the following signs, seek veterinary care immediately: - Pale gums: Instead of pink, they appear white or very pale pink. - Jaundice: The gums, whites of the eyes, and inner ears turn yellow. - Dark reddish-brown urine: Pigments from destroyed red blood cells are excreted in the urine. - Severe lethargy: Your pet may refuse walks or struggle to stand. - Rapid breathing and heart rate: Panting occurs even at rest. - Loss of appetite and vomiting: Sudden refusal to eat.

A puppy’s gums and the whites of its eyes turning yellow due to jaundice symptoms

When to Go to the Emergency Room Immediately

If your pet’s gums turn pale or yellow, breathing becomes labored, they collapse and cannot stand, or they lose consciousness, seek immediate care at a 24-hour emergency animal hospital. IMHA can deteriorate rapidly within hours due to complications such as thrombosis (pulmonary embolism, DIC). During transport, avoid jostling the pet and keep them warmly wrapped to prevent hypothermia.

How Is It Diagnosed?

Diagnosis proceeds in three steps: blood tests, confirmation of the immune response, and identification of the underlying cause. First, a complete blood count (CBC) is performed to assess the severity of anemia and measure reticulocyte levels. Next, immune-mediated involvement is confirmed through slide agglutination tests, the Coombs test, and observation of spherocytes on blood smears. To identify secondary causes, abdominal ultrasound, chest X-rays, and infectious disease screening (including tick-borne diseases) are conducted concurrently. If non-regenerative anemia is suspected, a bone marrow aspirate may be necessary.

A veterinarian performing a blood smear examination under a microscope.

How Is Treatment Managed?

The cornerstone of treatment rests on three pillars: immunosuppression, transfusion support, and thrombosis prevention. - Immunosuppressants: Prednisolone, a glucocorticoid, is the primary medication, typically initiated at a dose of 2–3 mg/kg per day. If the response is slow, secondary immunosuppressants such as cyclosporine, azathioprine, or mycophenolate may be added at the veterinarian’s discretion. Dosages and schedules are tailored by the veterinarian based on the patient’s weight and clinical response. - Transfusion: Packed red blood cells or whole blood are administered when the packed cell volume (PCV) drops to critical levels. During transfusion, vital signs—including body temperature, heart rate, respiratory rate, blood pressure, and PCV—are closely monitored. - Antithrombotic therapy: Because IMHA carries a high risk of pulmonary thromboembolism, prophylaxis against blood clots is an essential consideration. - Treating the underlying cause: In secondary cases, the triggering factor—such as infection, medication, or neoplasia—is identified and treated concurrently. Hospitalization for intensive care is standard, with close monitoring required for anywhere from several days to several weeks, depending on the degree of improvement.

Breed-Specific Risks — Breeds to Watch Closely

IMHA is particularly common in Cocker Spaniels, Collies, English Springer Spaniels, Poodles, and Old English Sheepdogs. American Cocker Spaniels and English Springer Spaniels are also prone to phosphofructokinase (PFK) deficiency, a genetic disorder that presents with similar symptoms, making it crucial to differentiate between the two conditions. Although less common in cats than in dogs, IMHA in felines is often secondary and associated with Mycoplasma haemofelis infection. For dogs of these breeds, we recommend annual blood tests for early screening.

Essential Home Care Guidelines

Even after discharge, immunosuppressants must be continued while gradually tapering the dose over several months. Prednisolone should be slowly reduced based on the patient’s response; arbitrarily lowering the dose or stopping abruptly increases the risk of relapse. Here are the key management points to follow at home: - Strict adherence to dosing times: Administer medication exactly as scheduled without missing doses. - Infection prevention: Since immunity is compromised, limit contact with other pets and people. - Postpone vaccinations: Consult your veterinarian before administering vaccines during treatment or for a specified period after recovery. - Monitor weight and energy levels: Weigh your pet regularly and keep a record. - Regular follow-up visits: Do not miss scheduled blood test intervals.

A pet owner administering immunosuppressant medication to their dog at home.

Reviewed by a veterinarian

Dr. Tony — Punnawat Phongkittirak

Veterinarian

A veterinarian who majored in veterinary medicine at Khon Kaen University, Thailand, and completed the IVSA program at North Carolina State University in the United States. Drawing on clinical experience at animal hospitals, he works in the pet healthcare field and is dedicated to building a digital care environment that connects pet parents with veterinarians.

Frequently Asked Questions

Can IMHA be completely cured?

While some cats achieve complete remission—meaning symptoms disappear and they can maintain health off medication—there is always a risk of recurrence. Prognosis depends on the severity of the anemia and the presence of complications, particularly feline aortic thromboembolism (FATE), so we assess each case individually rather than relying on general survival rates. It is crucial to follow your veterinarian’s instructions to gradually taper the medication and provide consistent, long-term care.

Is it true that vaccinations can cause IMHA?

Cases of IMHA have been reported shortly after vaccination or medication administration, so we review recent vaccination and medication history during diagnosis. However, the exact timing and mechanism of vaccine-associated IMHA remain unclear and require further research. Given the significant benefits of vaccination, rather than avoiding it entirely, consult your veterinarian to adjust the schedule if your pet has a history of IMHA.

How much does the treatment cost?

The total cost can vary widely depending on the clinic and the severity of the condition, especially when initial hospitalization, diagnostic tests, and blood transfusions are included. Since long-term medication may be needed for several months, having pet insurance can be a significant help. For the most accurate estimate, it’s best to consult directly with your veterinary clinic.

Can cats get IMHA?

Yes, cats can get it too. However, it's less common than in dogs, and it's often secondary to infections like **Mycoplasma haemofelis** (a blood parasite) or feline leukemia virus (FeLV). The principles of diagnosis and treatment are similar to those for dogs.

What should I do if it comes back?

If the condition recurs, we’ll apply a stronger immunosuppressive protocol than before or add a second medication. To catch any relapse early, regular blood tests are essential for at least one year after the initial treatment is completed.

Primary vs. Secondary Veterinary Hospitals: A Comparison

Comparing Dog Vaccine Types (3-way, 5-way, 7-way): Differences and How to Choose

Pet Insurance Enrollment Timing Comparison: When Is the Most Advantageous Time to Enroll?

Frequently Asked Questions About Feline Pneumothorax — Key Information for Pet Owners

Frequently Asked Questions About Feline Pleural Effusion — Key Information for Pet Owners

Frequently Asked Questions About Feline Oxygen Therapy — Key Information Every Pet Owner Should Know

Frequently Asked Questions About Feline Nebulizer Therapy — Key Information Every Cat Owner Should Know

Feline Nasal Polyps: Frequently Asked Questions (Q&A) — Key Information for Pet Owners

Feline Nasal Tumors FAQ — Key Information Every Pet Owner Should Know

Frequently Asked Questions About Feline Lung Auscultation Findings — Key Points for Pet Owners

References

[1] Notes on Canine Internal Medicine, 4th Edition — Chapter 5.4.2 Immune-Mediated Haemolytic Anaemia (IMHA)

[2] Fundamentals of Veterinary Clinical Pathology, 3rd Edition — Precursor-targeted Immune-Mediated Anemia (PIMA)

[3] Clinical Medicine of the Dog and Cat, 4th Edition — Chapter 16 Hematologic Disorders

[4] ACVIM Consensus Statement on the Treatment of Immune-Mediated Hemolytic Anemia in Dogs (2019)